新辅助治疗后即刻假体与自体乳房重建结局比较
该回顾性研究比较了新辅助治疗后即刻假体乳房重建(IBBR)与自体乳房重建(ABR)的并发症、美学效果和患者满意度。172例患者中,IBBR组重建失败率和感染率显著高于ABR组,患者满意度评分显著低于ABR组,组织扩张器阶段美学优秀率也显著更低。结论提示NAT后ABR的并发症更少、满意度更高、美学效果更好。
要点
- NAT后IBBR的重建失败率和感染率显著高于ABR。
- IBBR组患者满意度评分显著低于ABR组。
- 糖尿病显著增加IBBR组重建失败风险。
核心结论
- 新辅助治疗后,自体乳房重建较假体乳房重建并发症更少、患者满意度更高、美学效果更好。
研究设计与样本
- 回顾性分析接受新辅助治疗后行单侧即刻乳房重建患者的资料,共纳入172例,其中IBBR组97例、ABR组75例。
主要发现
- IBBR组重建失败率18.6%,ABR组1.3%,差异有统计学意义(p<0.001)。
- IBBR组感染率13.4%,ABR组4.0%,差异有统计学意义(p=0.035)。
- IBBR组患者满意度评分65.52±19.50,ABR组72.22±18.26,差异有统计学意义(p=0.035)。
- 组织扩张器阶段美学评价为「excellent」的比例IBBR组65.6%,ABR组89.5%,差异有统计学意义(p=0.002)。
关键数值与推荐
- 多因素回归显示,糖尿病显著增加IBBR组重建失败风险(OR=16.14,95%CI:1.46-178.51,p=0.023)。
- 感染也是IBBR组重建失败的显著风险因素(OR=5.26,95%CI:1.43-19.38,p=0.013)。
临床怎么用
- 新辅助治疗后行即刻乳房重建时,应充分考虑IBBR较高的失败与感染风险,尤其对合并糖尿病的患者。
- 与患者沟通重建方式时,可将ABR在满意度和美学效果上的优势纳入决策参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The choice of modality for immediate breast reconstruction (IBR) following neoadjuvant therapy (NAT) remains controversial. We compared the complications, aesthetic outcomes, and patient satisfaction between two IBR techniques, immediate autologous breast reconstruction (ABR) and implant-based breast reconstruction (IBBR), in patients treated with NAT, with the goal of informing clinical practice. METHODS: Data from patients who underwent unilateral IBR after receiving NAT were retrospectively analyzed. Demographic characteristics, tumour profiles, treatment regimens, complication data, patient-reported outcomes, and aesthetic scores were compared between the groups. Subgroup analyses were also conducted separately for each group. RESULTS: Of 172 patients who were included in the study, 97 underwent IBBR and 75 underwent ABR. Reconstruction failures (18.6% vs. 1.3%, p<0.001) and infection (13.4% vs. 4.0%, p=0.035) occurred more frequently in the IBBR than in the ABR group. Multivariable regression analysis showed that diabetes significantly increased reconstruction failure risk in the IBBR group (OR=16.14, 95% CI: 1.46-178.51, p=0.023), with infection also emerging as a notable risk factor (OR=5.26, 95% CI: 1.43-19.38, p=0.013). The IBBR group demonstrated significantly lower patient satisfaction scores compared to ABR patients (65.52±19.50 vs. 72.22±18.26, p=0.035). Aesthetic outcomes were analyzed by reconstruction stage, with significantly fewer people reporting "excellent" in the IBBR group than in the ABR group at the tissue expander phase (TEP) (65.6% vs. 89.5%, p=0.002). CONCLUSION: Following NAT, fewer complications, higher patient satisfaction, and better aesthetic outcomes were observed with ABR compared to IBBR.
引用
- Lin Z, Yin J. Outcomes of immediate implant-based vs. autologous breast reconstruction after neoadjuvant therapy. J Plast Reconstr Aesthet Surg. 2026. PMID: 41610825. doi:10.1016/j.bjps.2026.01.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。